{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:07:34Z","timestamp":1790356054203,"version":"4.1.0"},"reference-count":56,"publisher":"European Respiratory Society (ERS)","issue":"6","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002848","name":"Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["FONDEF 2016, IT16I10084"],"award-info":[{"award-number":["FONDEF 2016, IT16I10084"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2020,4,3]]},"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p>The severe respiratory consequences of the coronavirus disease 2019 (COVID-19) pandemic have prompted urgent need for novel therapies. Cell-based approaches, primarily using mesenchymal stem (stromal) cells (MSCs), have demonstrated safety and possible efficacy in patients with acute respiratory distress syndrome (ARDS), although they are not yet well studied in respiratory virus-induced ARDS. Limited pre-clinical data suggest that systemic MSC administration can significantly reduce respiratory virus (influenza strains H5N1 and H9N2)-induced lung injury; however, there are no available data in models of coronavirus respiratory infection.<\/jats:p><jats:p>There is a rapidly increasing number of clinical investigations of cell-based therapy approaches for COVID-19. These utilise a range of different cell sources, doses, dosing strategies and targeted patient populations. To provide a rational strategy to maximise potential therapeutic use, it is critically important to understand the relevant pre-clinical studies and postulated mechanisms of MSC actions in respiratory virus-induced lung injuries. This review presents these, along with consideration of current clinical investigations.<\/jats:p>","DOI":"10.1183\/13993003.00858-2020","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T21:54:27Z","timestamp":1586296467000},"page":"2000858","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":202,"title":["Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19"],"prefix":"10.1183","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9965-6266","authenticated-orcid":false,"given":"Maroun","family":"Khoury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimena","family":"Cuenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda F.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9387-094X","authenticated-orcid":false,"given":"Fernando E.","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia R.M.","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"2024102101325024000_55.6.2000858.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017"},{"key":"2024102101325024000_55.6.2000858.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13940-6"},{"key":"2024102101325024000_55.6.2000858.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"2024102101325024000_55.6.2000858.4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02369-2017"},{"key":"2024102101325024000_55.6.2000858.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2018.05.004"},{"key":"2024102101325024000_55.6.2000858.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2009.05.003"},{"key":"2024102101325024000_55.6.2000858.7","doi-asserted-by":"publisher","DOI":"10.1002\/stem.544"},{"key":"2024102101325024000_55.6.2000858.8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/sctm.17-0278","article-title":"Mesenchymal stem cell microvesicles restore protein permeability across primary cultures of injured human lung microvascular endothelial cells","volume":"7","author":"Hu","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"2024102101325024000_55.6.2000858.9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1164\/rccm.201701-0107CP","article-title":"Fifty years of research in ARDS. Cell-based therapy for acute respiratory distress syndrome. Biology and potential therapeutic value","volume":"196","author":"Laffey","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102101325024000_55.6.2000858.10","doi-asserted-by":"crossref","first-page":"e48052","DOI":"10.15252\/embr.201948052","article-title":"Mitochondrial transfer from MSCs to T cells induces Treg differentiation and restricts inflammatory response","volume":"21","author":"Court","year":"2020","journal-title":"EMBO Rep"},{"key":"2024102101325024000_55.6.2000858.11","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2736"},{"key":"2024102101325024000_55.6.2000858.12","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2007-0454"},{"key":"2024102101325024000_55.6.2000858.13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010088"},{"key":"2024102101325024000_55.6.2000858.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201206-0990OC"},{"key":"2024102101325024000_55.6.2000858.15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201410-1765OC"},{"key":"2024102101325024000_55.6.2000858.16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13287-016-0395-z","article-title":"Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice","volume":"7","author":"Li","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"2024102101325024000_55.6.2000858.17","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200738129"},{"key":"2024102101325024000_55.6.2000858.18","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/leu.2014.273","article-title":"Mesenchymal stromal cells inhibit proliferation of virus-specific CD8+ T cells","volume":"28","author":"Malcherek","year":"2014","journal-title":"Leukemia"},{"key":"2024102101325024000_55.6.2000858.19","first-page":"317801","article-title":"Human umbilical cord mesenchymal stem cells inhibit the function of allogeneic activated V\u03b39V\u03b42 T lymphocytes in vitro","volume":"2015","author":"Liu","year":"2015","journal-title":"Biomed Res Int"},{"key":"2024102101325024000_55.6.2000858.20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-119370"},{"key":"2024102101325024000_55.6.2000858.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.11.018."},{"key":"2024102101325024000_55.6.2000858.22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-virology-031413-085537","article-title":"IFITM-family proteins: the cell's first line of antiviral defense","volume":"1","author":"Bailey","year":"2014","journal-title":"Annu Rev Virol"},{"key":"2024102101325024000_55.6.2000858.23","doi-asserted-by":"crossref","first-page":"860950","DOI":"10.1155\/2015\/860950","article-title":"Mesenchymal stromal cells and viral infection","volume":"2015","author":"Thanunchai","year":"2015","journal-title":"Stem Cells Int"},{"key":"2024102101325024000_55.6.2000858.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.dci.2009.12.008"},{"key":"2024102101325024000_55.6.2000858.25","doi-asserted-by":"publisher","DOI":"10.3727\/096368912X656063"},{"key":"2024102101325024000_55.6.2000858.26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081805"},{"key":"2024102101325024000_55.6.2000858.27","doi-asserted-by":"crossref","first-page":"e0163709","DOI":"10.1371\/journal.pone.0163709","article-title":"Respiratory syncytial virus-infected mesenchymal stem cells regulate immunity via interferon beta and indoleamine-2,3-dioxygenase","volume":"11","author":"Cheung","year":"2016","journal-title":"PLoS One"},{"key":"2024102101325024000_55.6.2000858.28","doi-asserted-by":"crossref","unstructured":"Hoffmann M , Kleine-Weber H , Kr\u00fcger N , et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv 2020; preprint [ https:\/\/doi.org\/10.1101\/2020.01.31.929042 ].","DOI":"10.1101\/2020.01.31.929042"},{"key":"2024102101325024000_55.6.2000858.29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int J Oral Sci"},{"key":"2024102101325024000_55.6.2000858.30","doi-asserted-by":"crossref","unstructured":"Ziegler C , Allon SJ , Nyquist SK , et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is enriched in specific cell subsets across tissues. SSRN 2020; preprint [ https:\/\/doi.org\/10.2139\/ssrn.3555145 ].","DOI":"10.2139\/ssrn.3555145"},{"key":"2024102101325024000_55.6.2000858.31","doi-asserted-by":"crossref","first-page":"5432134","DOI":"10.1155\/2019\/5432134","article-title":"Strategies to enhance mesenchymal stem cell-based therapies for acute respiratory distress syndrome","volume":"2019","author":"Han","year":"2019","journal-title":"Stem Cells Int"},{"key":"2024102101325024000_55.6.2000858.32","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00009.2008"},{"key":"2024102101325024000_55.6.2000858.33","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3727\/096368914X685087","article-title":"Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury","volume":"24","author":"He","year":"2015","journal-title":"Cell Transplant"},{"key":"2024102101325024000_55.6.2000858.34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jcp.24794","article-title":"MSCs modified with ACE2 restore endothelial function following LPS challenge by inhibiting the activation of RAS","volume":"230","author":"He","year":"2015","journal-title":"J Cell Physiol"},{"key":"2024102101325024000_55.6.2000858.35","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1080\/14712598.2016.1218845","article-title":"Prospects and progress in cell therapy for acute respiratory distress syndrome","volume":"16","author":"Cruz","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"2024102101325024000_55.6.2000858.36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147170"},{"key":"2024102101325024000_55.6.2000858.37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071761"},{"key":"2024102101325024000_55.6.2000858.38","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00110.2014"},{"key":"2024102101325024000_55.6.2000858.39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1601911113"},{"key":"2024102101325024000_55.6.2000858.40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13287-018-0774-8","article-title":"Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model","volume":"9","author":"Khatri","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"2024102101325024000_55.6.2000858.41","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/infdis\/jiy478","article-title":"Therapeutic implications of human umbilical cord mesenchymal stromal cells in attenuating influenza A(H5N1) virus-associated acute lung injury","volume":"219","author":"Loy","year":"2019","journal-title":"J Infect Dis"},{"key":"2024102101325024000_55.6.2000858.42","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-016-0317-0"},{"key":"2024102101325024000_55.6.2000858.43","doi-asserted-by":"crossref","first-page":"9415367","DOI":"10.1155\/2018\/9415367","article-title":"Bioprocessing of mesenchymal stem cells and their derivatives: toward cell-free therapeutics","volume":"2018","author":"Phelps","year":"2018","journal-title":"Stem Cells Int"},{"key":"2024102101325024000_55.6.2000858.44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000849"},{"key":"2024102101325024000_55.6.2000858.45","doi-asserted-by":"crossref","unstructured":"Bao L , Deng W , Huang B , et al. The pathogenicity of 2019 novel coronavirus in hACE2 transgenic mice. bioRxiv 2020; preprint [ https:\/\/doi.org\/10.1101\/2020.02.07.939389 ].","DOI":"10.1101\/2020.02.07.939389"},{"key":"2024102101325024000_55.6.2000858.46","doi-asserted-by":"crossref","unstructured":"Bao L , Deng W , Gao H , et al. Reinfection could not occur in SARS-CoV-2 infected rhesus macaques. bioRxiv 2020; preprint [ https:\/\/doi.org\/10.1101\/2020.03.13.990226 ].","DOI":"10.1101\/2020.03.13.990226"},{"key":"2024102101325024000_55.6.2000858.47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2\u2212 mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis"},{"key":"2024102101325024000_55.6.2000858.48","doi-asserted-by":"crossref","unstructured":"Chen J , Hu C , Chen L , et al. Clinical study of mesenchymal stem cell treating acute respiratory distress syndrome induced by epidemic Influenza A (H7N9) infection, a hint for COVID-19 treatment. Engineering 2020; in press [ https:\/\/doi.org\/10.1016\/j.eng.2020.02.006 ].","DOI":"10.1016\/j.eng.2020.02.006"},{"key":"2024102101325024000_55.6.2000858.49","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-020-0233-6"},{"key":"2024102101325024000_55.6.2000858.50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102101325024000_55.6.2000858.51","unstructured":"World Health Organization . Guidance for managing ethical issues in infectious disease outbreaks. Geneva, World Health Organization, 2016. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/250580"},{"key":"2024102101325024000_55.6.2000858.52","unstructured":"Athersys Inc . Athersys announces positive results from its exploratory clinical study of multistem cell therapy for treatment of acute respiratory distress syndrome (ARDS). www.athersys.com\/investors\/press-releases\/press-release-details\/2019\/Athersys-Announces-Positive-Results-From-Its-Exploratory-Clinical-Study-of-MultiStem-Cell-Therapy-for-Treatment-of-Acute-Respiratory-Distress-Syndrome-ARDS\/default.aspx Date last updated: 23 January 2019."},{"key":"2024102101325024000_55.6.2000858.53","doi-asserted-by":"crossref","unstructured":"Keusch G , McAdam K , Cuff PA , et al. , eds. Integrating Clinical Research into Epidemic Response: The Ebola Experience. Washington, National Academies Press, 2017.","DOI":"10.17226\/24739"},{"key":"2024102101325024000_55.6.2000858.54","unstructured":"International Society for Cell and Gene Therapy (ISCT) . ISCT releases statement on unproven stem cell treatments for COVID-19. https:\/\/isctglobal.org\/news\/494824\/ISCT-Releases-Statement-on-Unproven-Stem-Cell-Treatments-for-COVID-19.htm Date last updated and accessed: 20 March 2020."},{"key":"2024102101325024000_55.6.2000858.55","unstructured":"EuroStemCell . Stem cells and COVID-19. www.eurostemcell.org\/stem-cells-and-covid-19 Date last updated: 12 March 2020. Date last accessed: 18 March 2020."},{"key":"2024102101325024000_55.6.2000858.56","unstructured":"International Society for Stem Cell Research (ISSCR). ISSCR statement regarding the marketing of unproven stem cell treatments for COVID-19. www.isscr.org\/news-publicationsss\/isscr-news-articles\/article-listing\/2020\/03\/06\/isscr-statement-regarding-the-marketing-of-unproven-stem-cell-treatments-for-covid-19 Date last updated: 6 March 2020. Date last accessed: 18 March 2020."}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00858-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:31:55Z","timestamp":1740382315000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00858-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":56,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,4]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1183\/13993003.00858-2020"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00858-2020","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]}}}